DE1813228A1 - delta?-19-nor-5beta-Steroide und Verfahren zu ihrer Herstellung - Google Patents

delta?-19-nor-5beta-Steroide und Verfahren zu ihrer Herstellung

Info

Publication number
DE1813228A1
DE1813228A1 DE19681813228 DE1813228A DE1813228A1 DE 1813228 A1 DE1813228 A1 DE 1813228A1 DE 19681813228 DE19681813228 DE 19681813228 DE 1813228 A DE1813228 A DE 1813228A DE 1813228 A1 DE1813228 A1 DE 1813228A1
Authority
DE
Germany
Prior art keywords
solution
formula
mixture
methylene
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681813228
Other languages
German (de)
English (en)
Inventor
Maarples Brian Arthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of DE1813228A1 publication Critical patent/DE1813228A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C5/00—Filling or capping teeth
    • A61C5/60—Devices specially adapted for pressing or mixing capping or filling materials, e.g. amalgam presses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Steroid Compounds (AREA)
DE19681813228 1967-12-06 1968-12-06 delta?-19-nor-5beta-Steroide und Verfahren zu ihrer Herstellung Pending DE1813228A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5541267 1967-12-06

Publications (1)

Publication Number Publication Date
DE1813228A1 true DE1813228A1 (de) 1969-06-19

Family

ID=10473825

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681813228 Pending DE1813228A1 (de) 1967-12-06 1968-12-06 delta?-19-nor-5beta-Steroide und Verfahren zu ihrer Herstellung

Country Status (4)

Country Link
DE (1) DE1813228A1 (cg-RX-API-DMAC7.html)
FR (1) FR8465M (cg-RX-API-DMAC7.html)
GB (1) GB1231003A (cg-RX-API-DMAC7.html)
NL (1) NL6817446A (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
NL6817446A (cg-RX-API-DMAC7.html) 1969-06-10
FR8465M (cg-RX-API-DMAC7.html) 1972-01-07
GB1231003A (cg-RX-API-DMAC7.html) 1971-05-05

Similar Documents

Publication Publication Date Title
DE1172671B (de) Verfahren zur Herstellung von 17ª‰-Hydroxy-androstan-(3, 2-c)-pyrazol oder eines 17ª‰-Hydroxy-17ª‡-niederes-Alkyl-androstan-(3, 2-c)-pyrazols
CH494216A (de) Verfahren zur Herstellung von in 3-Stellung einer verätherte Hydroxygruppe tragenden 6-Aminomethyl- 3,5-steroiden
DE1172670B (de) Verfahren zur Herstellung von 3-substituierten D-Homo-18-nor-androst-13(17a)-en-17-on-derivaten
DE1793641C2 (de) Verfahren zur Herstellung von 17-Halogenalkinyl 3-ketogonen und deren Verwendung. Ausscheidung aus: 1468988
DE1518666A1 (de) Verfahren zur Herstellung von 13,14-Seco-steroiden
DE1468864C3 (de) Verfahren zur Herstellung von 6 beta, 19-bzw. 11 beta, 18-Oxidosteroiden oder 18,11 beta-Jodhydrinen bzw. 18-Jod-llketonen
DE2037402B2 (cg-RX-API-DMAC7.html)
CH494213A (de) Verfahren zur Herstellung von Gonadienonen
DE825686C (de) Verfahren zur UEberfuehrung von í¸-20-Cyanpregnenen mit einer oder mehreren kerngebundenen Hydroxylgruppen in 17 alpha-Oxy-20-ketopregnane
DE965326C (de) Verfahren zur Herstellung von 23-Brom-5ª‡, 22-a-spirostan-3ª‰, 12ª‰-diol-11-on
DE940462C (de) Verfahren zur Herstellung von Epoxyden von in 7 (8)- und 9 (11)-Stellung ungesaettigten Steroiden
DE1238021B (de) Verfahren zur Herstellung von Verbindungen der Pregnanreihe
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
AT206593B (de) Verfahren zur Herstellung von 6-Methyl-3-oxo-Δ<4>-steroiden
DE1668665C (de) Verfahren zur Herstellung von 13-Alky 1-gona-1,3,5( 10)-trienen. Ausscheidung aus: 1443123
DE1418857C (de) Verfahren zur Herstellung von 3beta-Hydroxy-(bzw.-Acyloxy)-9alpha, llbeta-dichlor-lobeta-methyl-Salphasteroiden der Pregnanreihe
DE1443082B1 (de) Tetracyclische Dienketone
DE2710062A1 (de) Neue cholesterinderivate
DD144548A1 (de) Verfahren zur herstellung von pregna-1,4-dien-3,20-dion
DE1142362B (de) Verfahren zur Herstellung von Enolacylaten von 16ª‡-Alkyl-20-ketosteroiden der Pregnan- und Allopregnanreihe
CH308891A (de) Verfahren zur Herstellung von 3-Acetoxy-11-keto-tigogenin.
DE1793598B1 (de) 13-Alkyl-gona-1,3,5(10),8-tetraene
DE1418856A1 (de) Steroide und Verfahren zu ihrer Herstellung
CH390910A (de) Verfahren zur Herstellung von 19-Nor- 5-androsten-3B,17B-diolen
CH238516A (de) Verfahren zur Herstellung eines Lactons.